SCHEMBL28510087

SCHEMBL28510087

CN1CCN(Cc2ccc(-c3cnc4[nH]ccc4n3)cc2)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K11 Q16584 5/20 0.55
MAPK1 P28482 9/20 0.55
IKBKB O14920 2/20 0.55
CHUK O15111 2/20 0.55
ABL1 P00519 2/20 0.55
INSR P06213 2/20 0.55
CDK2 P24941 2/20 0.55
FLT3 P36888 2/20 0.55
RIPK1 Q13546 1/20 0.53
TNIK Q9UKE5 8/20 0.51
SGK1 O00141 1/20 0.51
AURKA O14965 1/20 0.51
PRKAB2 O43741 1/20 0.51
ROCK2 O75116 1/20 0.51
NTRK1 P04629 1/20 0.51
LCK P06239 1/20 0.51
CDK1 P06493 1/20 0.51
IGF1R P08069 1/20 0.51
MET P08581 1/20 0.51
CYP3A4 P08684 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15171446 0.83 MAP3K11 (0.58) MAP3K11MAPK1IKBKBCHUKABL1
SCHEMBL28508679 0.81 MAPK1 (0.59) MAPK1FLT3RIPK1
SCHEMBL15154791 0.80 MAP3K11 (0.80) MAP3K11MAPK1IKBKBCHUKABL1
SCHEMBL28506193 0.78 TNIK (0.53) MAP3K11MAPK1IKBKBCHUKABL1
SCHEMBL18197658 0.76 MAP3K11 (0.73) MAP3K11MAPK1IKBKBCHUKABL1
SCHEMBL28513749 0.75 MAPK1 (0.54) MAPK1RIPK1
SCHEMBL30641871 0.75 MAPK1 (0.54) MAPK1RIPK1
SCHEMBL28769143 0.75 MAPK1 (0.56) MAPK1FLT3RIPK1SYKAURKB
SCHEMBL29888818 0.75 MAPK1 (0.56) MAPK1FLT3RIPK1SYKAURKB
SCHEMBL7874293 0.75 MAP3K11 (0.61) MAP3K11MAPK1IKBKBCHUKABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112243439-A Pyrrolo [2,3-B ] pyridines or pyrrolo [2,3-B ] pyrazines as HPK1 inhibitors and uses thereof 百济神州有限公司 2021-01-19 CN disclosed